Form 4 for CVS CVS Health
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-01 · accession 0001127602-21-028310 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-03 | 2021-11-01 | CVS | Brennan Troyen A | EVP, Chief Medical Off | M - OptEx | $58.34 | +28.2K | 166.4K | +20% | +$1.64M |
| D | 2021-11-03 | 2021-11-01 | CVS | Brennan Troyen A | EVP, Chief Medical Off | S - Sale+OE | $90.00 | -28.2K | 138.2K | -17% | -$2.53M |
| D | 2021-11-03 | 2021-11-01 | CVS | Brennan Troyen A | EVP, Chief Medical Off | M - OptEx | $0.00 | -28.2K | 84.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-01 | M | A | 28,159 | $58.34 | 166,405.06 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-01 | S | D | 28,159 | $90.00 | 138,246.06 | D | — | — | |
| 3 | Derivative | Stock Option | 2021-11-01 | M | D | 28,159 | $0.00 | 84,478 | D | $58.34 · 2021-04-01 to 2030-04-01 | 28,159 Common Stock | (F1) The number of shares subject to the option were calculated using a 30-day average price. (F2) Options became exercisable in four equal annual installments, commencing 4/1/2021. |